Skip to content

Analgesic effect of local anesthesia under uterine serosa and pseudocapsule in ultrasound-guided hysteromyoma thermal ablation

Analgesic effect of local anesthesia under uterine serosa and pseudocapsule in ultrasound-guided hysteromyoma thermal ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037912
Enrollment
Unknown
Registered
2020-09-04
Start date
2020-09-06
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leiomyoma of uterus

Interventions

Case series:Thermal ablation of uterine fibroids under local anesthesia

Sponsors

Zhejiang Rongjun hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The International Federation of gynecology and Obstetrics (FIGO) grade 0-6 for patients with hysteromyoma diagnosed by MRI and ultrasonography; 2. Patients with menorrhagia, secondary anemia, abdominal pain, compression and other symptoms; 3. There was no perimenopausal sign; 4. Patients with safe puncture path through abdominal wall; 5. Patients without history of local anesthetic allergy; 6. Patients who can comply with the research requirements and follow-up procedures, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with uterine malignant lesions (uterine sarcoma, uterine fibroids with cervical cancer or endometrial cancer or ovarian cancer and other gynecological malignancies); 2. Patients during menstruation, pregnancy or lactation; 3. Patients with hysteromyoma of FIGO grade 7; 4. Patients without a safe percutaneous puncture path (the lesions adhere to the important organs such as intestine, bladder and great vessels and cannot be separated); 5. Patients with uncontrolled acute pelvic inflammation; 6. Patients with liver and kidney dysfunction; 7. In patients with severe coagulation dysfunction, platelet 25 s, prothrombin activity < 40%; 8. Patients with local anesthetic allergy.

Design outcomes

Primary

MeasureTime frame
Intraoperative pain score;

Countries

China

Contacts

Public ContactMeng Bin

Zhejiang Rongjun hospital

doc.mb@163.com+86 15957320800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026